Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Nerve-Sparing Prostatectomy & ED

Cavernous Nerve Preservation in Radical Prostatectomy

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Surgical technique (not an FDA-regulated product)

Reference only. Not medical advice.

What can go wrong

Even with bilateral nerve sparing, a substantial proportion of men experience temporary or permanent ED, and oncologic control must take priority over potency, meaning nerve sparing is not always feasible. Other risks include urinary incontinence and changes in orgasm and ejaculation. Outcomes vary widely by surgeon experience and patient factors.

This is something to take to a clinician. The Atlas can tell you what is known about nerve-sparing prostatectomy & ed in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Radical prostatectomy for prostate cancer historically caused near-universal erectile dysfunction because the cavernous nerves run alongside the prostate. The nerve-sparing technique, pioneered by Patrick Walsh in the early 1980s, preserves these neurovascular bundles to improve postoperative potency. Outcomes depend on age, baseline function, cancer extent, surgeon volume, and whether one or both bundles are spared; recovery can take 12-24 months and is supported by penile rehabilitation.

The Walsh technique that turned radical prostatectomy from a near-certain cause of impotence into a potency-sparing operation.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Potency preservation during radical prostatectomy
  • Bilateral or unilateral nerve sparing in localized prostate cancer
  • Foundation for post-prostatectomy penile rehabilitation

How it works

The cavernous nerves carry the parasympathetic signals that initiate erection and run within neurovascular bundles on the posterolateral surface of the prostate. Nerve-sparing dissection preserves these bundles where oncologically safe, maintaining the neural pathway for erection. Even when anatomically spared, nerves undergo a neuropraxia (temporary injury) that explains delayed recovery and the rationale for rehabilitation.

Safety in detail

Radical prostatectomy is a major surgical procedure with significant risks including erectile dysfunction, urinary incontinence, and ejaculatory changes. Technique selection and outcomes require evaluation by a qualified urologic surgeon, with cancer control prioritized over potency preservation.

What people get wrong

  • Often saidNerve sparing guarantees normal erections

    ActuallyEven bilateral sparing leaves many men with ED; nerves are bruised and recovery is gradual and incomplete for some.

  • Often saidYou can always have nerve-sparing surgery

    ActuallyCancer location and extent may make sparing unsafe; cancer cure comes first.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Technique origin
Patrick Walsh, ~1982
Nerves at risk
Cavernous (neurovascular) bundles
Recovery window
Often 12-24 months
Predictors
Age, baseline potency, bilateral vs unilateral sparing, surgeon volume

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Nerve-Sparing Prostatectomy & ED. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Walsh anatomic nerve-sparing description1982

    Defined the course of the cavernous nerves and the potency-preserving technique

  • Penile rehabilitation after prostatectomy trials2000s

    PDE5 inhibitors and other rehab strategies studied to aid potency recovery; benefit on long-term spontaneous function is debated

  • Robotic vs open potency outcomes2010s

    Comparative series examined potency recovery; surgeon volume strongly influences results